Related references
Note: Only part of the references are listed.Use of Hormone Replacement Therapy and the Risk of Colorectal Cancer
Gad Rennert et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma
Ruey-Nan Chen et al.
CANCER RESEARCH (2008)
Role of lipid peroxidation and oxidative stress in the association between thyroid diseases and breast cancer
Manuela Gago-Dominguez et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women
Polly A. Newcomb et al.
CANCER RESEARCH (2007)
The decrease in breast-cancer incidence in 2003 in the United States.
Peter M. Ravdin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs
I. H. Chan et al.
ONCOGENE (2006)
Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery
E Giustarini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Associations between ERα, ERβ, and AR genotypes and colon and rectal cancer
ML Slattery et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Hypothyroidism might be related to breast cancer in post-menopausal women
JLP Kuijpens et al.
THYROID (2005)
Chronic treatment with low doses of estradiol affects pituitary and thyroid function in young and middle-aged ovariectomized rats
M Böttner et al.
BIOGERONTOLOGY (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation of estrogen response element dependent transcription by thyroid hormone with increase in estrogen receptor levels in a rat pituitary cell line, GH3
N Fujimoto et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Estrogen plus progestin and colorectal cancer in postmenopausal women
RT Chlebowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Thyroid hormone receptor mutations in cancer
SY Cheng
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
β-Catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone
H Natsume et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-α protein:: Estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary
ET Alarid et al.
ENDOCRINOLOGY (2003)
Hormone replacement therapy and cancer risk: A systematic analysis from a network of case-control studies
E Fernandez et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Evidence from randomised trials on the long-term effects of hormone replacement therapy
V Beral et al.
LANCET (2002)
Postmenopausal hormone replacement therapy - Scientific review
HD Nelson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells
S Dinda et al.
ONCOGENE (2002)